ANN ARBOR, Mich., Nov. 19, 2024 /PRNewswire/ -- Ambient Biosciences, a pioneering life science company, today announced the launch of its Early Access Program (EAP), seeking partners to trial ...

Northwestern State University's Department of Biology and Microbiology has made an agreement with the University of Texas at Tyler.

Lung cancer diagnostics developer LungLife AI reported significant progress in the commercialisation of its ‘LungLB’ test on ...

Ten participants (6 debamestrocel, 4 placebo) from Brainstorm's prior Phase 3 clinical trial (BCT-002-US) were enrolled in an open label Expanded Access Program (EAP). The EAP spanned two 28-week ...

Ambient Biosciences, a pioneering life science company, today announced the launch of its Early Access Program (EAP), seeking ...

Given the speed of this transition, we anticipate closing the EAP program in the second ... We are pleased with the early progress with regards to enrollments and on future calls, we intend to provide ...

FDA approval of MIPLYFFA™ and product launch cap third quarter filled with multiple commercial and clinical development milestonesZevra received ...

today announced the launch of its MXL-Gen1 Photonic Cooling Early Access Program (EAP) during the SC24 conference in Atlanta, GA Nov 17-22. This exclusive program offers select customers priority ...

For small-business owners, offering an EAP (employee assistance program) probably isn’t the most pressing thing on their to-do list. However, having access to an EAP can make all the difference ...

The Board and Chief Executive Officer of Cereno Scientific AB here present the interim report for Q3 2024 (July 1-September 30). Summary of the interim report for Q3 2024 (July 1-September 30) Cereno ...